Tumor cell lysis could also account for the increased levels of sNKG2DL in the treated mice as well, and similar observations have been made in pediatric patients suffering from r/r leukemia after receiving NKG2D-CAR T cells (39). This evidence concerns the gene KLRK1 and leukemia.